Articles

This indication is approved under accelerated approval based on tumor response rate and durability of response.

FDA Grants Accelerated Approval to Dostarlimab for Advanced dMMR Endometrial Cancer

Nextstellis (drospirenone; estetrol) now is approved as a combined oral contraceptive for birth control.

FDA OKs New Combined Oral Contraceptive

AstraZeneca is preparing to submit its COVID-19 vaccine data to the FDA for emergency use authorization in the coming weeks. 

AstraZeneca’s COVID-19 Vaccine Data Show 79% Efficacy Against Symptomatic Disease 

The FDA has granted emergency use authorization status for the first single-dose vaccine for COVID-19 in the United States.

FDA Grants Emergency Use Authorization to Third COVID-19 Vaccine

Novartis’ sacubitril/valsartan (Entresto) is now indicated for use in the treatment of chronic heart failure. 

FDA OKs Expanded Indication for Heart Failure Treatment

Associate Clinical Professor, University of Connecticut School of Pharmacy, Storrs, CT.

Belantamab mafodotin-blmf is now indicated for adult patients with relapsed or refractory myeloma who have received at least 4 prior therapies. 

Belantamab mafodotin-blmf for Relapsed or Refractory Multiple Myeloma

Officials with the FDA have approved cabotegravir and rilpivirine, injectable formulation (Cabenuva; ViiV Healthcare) as a complete regimen for the treatment of HIV-1 infection in adults.

FDA OKs Long-Acting Injectable Drug Regimen for HIV Treatment

On October 22, 2020, the FDA approved remdesivir (Veklury; Gilead) as the first treatment for coronavirus disease 2019 (COVID-19).

Remdesivir in the Treatment of COVID-19

The market for acute lymphocytic leukemia and bladder cancer drug therapies is expected to soar over the next few years, thanks in part to new and innovative medications.

Leukemia, Bladder Cancer Drug Markets Expected to Soar

Here are some of the top-read FDA approvals covered by Drug Topics® from this year.

New Products